Page 152 - Read Online
P. 152

gravis. J Clin Neurosci 2002;9:243‑6.           51.  Tzartos  SJ, Sophianos  D, Efthimiadis  A. Role of the main
           37.  Jaretzki A 3 , Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC,   immunogenic region of acetylcholine receptor in myasthenia gravis.
                      rd
              Penn AS, Sanders DB. Myasthenia gravis: recommendations for   An Fab monoclonal antibody protects against antigenic modulation
              clinical research standards. Task Force of the Medical Scientific   by human sera. J Immunol 1985;134:2343‑9.
              Advisory Board of the Myasthenia Gravis Foundation of America.   52.  Lindstrom J, Anand R, Peng X, Gerzanich V, Wang F, Li Y. Neuronal
              Ann Thorac Surg 2000;70:327‑34.                     nicotinic receptor subtypes. In: Diversity of Interacting Receptors.
           38.  Folstein  MF, Folstein  SE, McHugh  PR. “Mini‑mental state”.   Birkhäuser Basel; 1995. p. 100‑16.
              A practical method for grading the cognitive state of patients for   53.  Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J,
              the clinician. J Psychiatr Res 1975;12:189‑98.      Smit AB, Sixma TK. Crystal structure of an ACh‑binding protein
           39.  Al‑Rajeh S, Ogunniyi A, Awada A, Daif A, Zaidan R. Preliminary   reveals the ligand‑binding domain of nicotinic receptors.  Nature
              assessment  of  an  Arabic  version  of  the  Mini‑Mental  state   2001;411:269‑76.
              examination. Ann Saudi Med 1999;19:150‑2.       54.  Ji D, Lape R, Dani JA. Timing and location of nicotinic activity
           40.  Delany EA, Hopkins TF. The Stanford. Binet Intelligence Scale:   enhances or depresses hippocampal synaptic plasticity. Neuron
              Examiner’s Handbook. 4  ed. Chicago: The Riverside Publishing   2001;31:131‑41.
                               th
              Co.; 1986.                                      55.  Darnell RB. Paraneoplastic neurologic disorders: windows into
           41.  Melika LK. The Stanford. Binet Intelligence Scale: Arabic Examiner’s   neuronal function and tumor immunity. Arch Neurol 2004;61:30‑2.
              Handbook. 4  ed. Cairo: Dar El Maref Publishing; 1998.  56.  Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G,
                       th
           42.  Wechsler  D. Wechsler Memory Scales‑Revised. New  York:   Lauriola L, Fattorossi A. Paraneoplastic diseases associated with
              Psychological Cooperation; 1987.                    thymoma. J Neurol 2007;254:756‑62.
           43.  Polich  J. P300 clinical utility and control of variability.  J  Clin   57.  Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated
              Neurophysiol 1998;15:14‑33.                         disorders in myasthenia gravis: autoimmune diseases and their
           44.  American Psychiatric Association. Diagnostic and Statistical Manual   relation to thymectomy. Acta Neurol Scand 1989;80:290‑5.
              of Mental Disorders. 4  ed. Washington, DC: American Psychiatric   58.  Low PA, Suarez GA. Diabetic neuropathies. Baillieres Clin Neurol
                             th
              Association; 1994. p. 317‑91.                       1995;4:401‑25.
           45.  Gharyb  AG. Beck Depression Inventory‑II  (BDI‑II), Arabic   59.  Manfredi  R, Fasulo  G, Fulgaro  C, Sabbatani  S. Associated
              Examiner’s Handbook. Cairo: Dar El‑Anglo Publishing; 2000.  thyreoiditis, myasthenia gravis, thymectomy, Chron’s disease,
           46.  Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression   and erythema nodosum: pathogenetic and clinical correlations,
              inventories‑IA  and‑II  in  psychiatric  outpatients.  J  Pers  Assess   immune system involvement, and systemic infectious complications.
              1996;67:588‑97.                                     Rheumatol Int 2008;28:1173‑5.
           47.  Bartel PR, Lotz BP. Neuropsychological test performance and affect   60.  Tola MR, Casetta I, Granieri E, Caniatti LM, Monetti VC, Pascarella R.
              in myasthenia gravis. Acta Neurol Scand 1995;91:266‑70.  Systemic lupus erythematosus related recurrent transverse myelitis in
           48.  Kirby AW, Wiley RW, Harding TH. Cholinergic effects on the visual   a patient with myasthenia gravis and multiple sclerosis. Eur Neurol
              evoked potential. In: Cracco RQ, Bodis‑Wollner I, editors. Evoked   1996;36:327‑8.
              Potentials. Alan R. Liss, New York; 1986. p. 296‑305.
           49.  Fotiou F, Papakostopoulos D, Hamlatzis P. Changes in the pattern   Cite this article as: Hamed SA, Youssef AH, Abd ElHameed MA, Mohamed
              reversal visual evoked potentials in myasthenia gravis. Electromyogr   MF, Elattar AM. Assessment of cognitive function in patients with myasthenia
              Clin Neurophysiol 1994;34:171‑5.                 gravis. Neuroimmunol Neuroinflammation 2014;1(3):141-6.
           50.  Jech R, Ruzicka E. Brain stem auditory evoked potentials reflect   Source of Support: Nil. Conflict of Interest: No.
              central nervous system involvement in myasthenia gravis. J Neurol
              1996;243:547‑50.                                 Received: 14-07-2014; Accepted: 25-08-2014









































            146                                             Neuroimmunol Neuroinflammation | Volume 1 | Issue 3 | December 2014
   147   148   149   150   151   152   153   154   155   156   157